Are you looking for information on the Global Health Limited IPO GMP? If so, you've come to the right place. In this blog post, we'll give you all the details you need to know about the Global Health IPO, including the dates, the timetable, and the market lot size. We'll also tell you a little bit about the company and its financial performance. So read on for everything you need to know about the Global Health Limited IPO GMP.
Global Health Limited IPO GMP
The Global Health Limited IPO GMP will begin on November 3, 2022, and end on November 7, 2022. The bid period for the Global Health IPO is from November 3, 2022, at 10:00 A.M. to November 7, 2022, at 5:00 P.M. The initial public offering (IPO) will include an offer-for-sale (OFS) of up to 5.08 crore equity shares as well as a fresh issue of equity shares totaling Rs 500 crore.
Global Health Limited is a leading provider of healthcare services in India with a network of hospitals across the country. The company offers a wide range of services including primary care, secondary care, and tertiary care. It also has a strong presence in the pharmacy and diagnostics segments.
The company was founded in 2006 by Dr. B S Ajaikumar and Dr. K Hari Prasad Reddy with the aim of providing quality healthcare services to all sections of society. Since its inception, Global Health has been focused on expanding its reach and improving its quality of care. In 2015, the company went public with an initial public offering (IPO) of Rs 500 crore.
The Global Health IPO is being managed by ICICI Securities Limited, HSBC Securities and Capital Markets (India) Private Limited, and Kotak Mahindra Capital Company Limited.
Global Health Limited IPO GMP Dates
The Global Health Limited IPO GMP will begin on November 3, 2022, and end on November 7, 2022. The bid period for the Global Health IPO is from November 3, 2022, at 10:00 A.M. to November 7, 2022, at 5:00 P.M.
This means that interested investors will have four days to place their bids for the IPO shares. The minimum bid lot size for the Global Health IPO has been set at Rs 2 lakh. This means that investors will need to apply for a minimum of 2 lakh shares in order to be considered for allotment.
The price band for the Global Health IPO has been set at Rs 145-146 per share. This means that investors can bid anywhere within this price range per share. The maximum application amount per investor has been set at Rs 10 lakh.
Global Health Limited is a Mumbai-based company that provides healthcare services including diagnostics, primary care, and day care surgeries. The company was founded in 2006 and has a network of over 60 diagnostic centers and over 30 primary care clinics across India.
Global Health Limited IPO GMP Tentative Timetable
The tentative timetable for the Global Health Limited IPO GMP is as follows:
November 3, 2022: The IPO will open for anchor investors.
November 7, 2022: The IPO will close for anchor investors.
November 9, 2022: The IPO will open for public subscription.
November 11, 2022: The IPO will close for public subscription.
November 16, 2022: The finalization of basis of allotment.
November 17, 2022: Unblocked of ASBA bank accounts.
November 18, 2022: Credit of shares to demat accounts.
November 19, 2022: Commencement of trading on stock exchanges.
About Global Health
Global Health Limited is a Mumbai-based company that provides healthcare services including diagnostics, primary care, and day care surgeries. It was founded in 2006 by Dr. Naresh Trehan, a world-renowned cardiologist, and Dr. Amit Mehta, an experienced healthcare entrepreneur. Global Health is one of the largest integrated healthcare providers in India with a network of 22 hospitals, over 1,600 diagnostic centres, and over 100 primary care clinics. The company has a strong presence in Tier 1 and Tier 2 cities in India with a total bed capacity of 4,800 beds.
Global Health's IPO is an offer for sale of up to 5.08 crore equity shares by existing shareholders and a fresh issue of equity shares totaling Rs 500 crore. The IPO will help the company raise funds for expansion plans and working capital requirements. The company plans to use the fresh issue proceeds to expand its network of hospitals and diagnostic centres and build new primary care clinics.
The IPO is being managed by Kotak Mahindra Capital Company Limited, Axis Capital Limited, Edelweiss Financial Services Limited, HSBC Securities and Capital Markets (India) Private Limited, ICICI Securities Limited, IIFL Securities Limited, SBI Capital Markets Limited, and Yes Securities (India) Limited.
Global Health Competitive Strengths
Global Health's competitive strengths include its experienced management team, strong brand equity, and extensive network of hospitals and diagnostic centres.
Dr. Naresh Trehan is a world-renowned cardiologist and the chairman and managing director of Global Health. He has over 40 years of experience in the healthcare industry. He is also the founder of Medanta, one of India's largest multi-specialty hospitals.
Dr. Amit Mehta is the co-founder and chief executive officer of Global Health. He has over 20 years of experience in the healthcare industry. Prior to joining Global Health, he was the managing director of Indian operations for Escorts Heart Institute and Research Centre.
Global Health has a strong brand equity with its "Treating You Better" tagline. The company has been ranked as one of the top three healthcare brands in India by Brand Finance. It has also been ranked amongst the top 100 most trusted brands in India by Brand Trust Report.
Global Health's network includes 22 hospitals, over 1,600 diagnostic centres, and over 100 primary care clinics. The company has a presence in 11 states and union territories in India. It also has an international presence with hospitals in Dubai and Mauritius.
Global Health Financial Performance (in Cr.)
Global Health's financial performance has been strong in recent years. The company's revenue has grown at a compound annual growth rate (CAGR) of 26.5% from FY2016 to FY2020. Its net profit has grown at a CAGR of 37.1% during the same period.
Global Health's hospital segment has been the largest contributor to its revenue, accounting for 70.4% of total revenue in FY2020. The company's diagnostic centres and primary care clinics have also contributed significantly to its revenue growth, with respective shares of 18.9% and 10.7%.
Global Health's operating margin has improved from 22.1% in FY2016 to 27.4% in FY2020. The improvement in margin is due to the company's focus on cost control and efficiency initiatives. Global Health's net profit margin has also improved from 11.4% in FY2016 to 16.5% in FY2020.
The company's strong financial performance is reflected in its balance sheet as well. As of March 31, 2020, Global Health had cash and cash equivalents of Rs 1,344 crore, which is equivalent to around 30% of its total debt of Rs 4,458 crore. This provides the company with significant financial flexibility to pursue its growth plans going forward."
0 Comments